NEW YORK—WCG, the healthcare communications group formerly known as WeissCom, has hired Jeff Yates as creative director in its New York office in an effort better serve the growing digital, creative and interactive needs of its clients. Yates joins WCG from DraftFCB Healthcare where he spent the last eight years as vice president and associate creative director. He will report to WCG’s chief creative officer Paulo Simas.
While at DraftFCB, Yates created the new corporate identity for ENDO Pharmaceuticals and launched several pharmaceuticals and medical devices, including GlaxoSmithKline’s Wellbutrin XL for depression and Valtrex for cold sores and genital herpes; a new indication for Merck’s Cozaar/Hyzaar for stroke risk reduction; and Abbott’s and Medtronic’s continuous glucose monitors. Most recently he worked on the product launch campaign for Johnson & Johnson’s Stelara for psoriasis.
Prior to DraftFCB, Yates was vice president and associate creative director for Lowe McAdams Healthcare where he oversaw the professional and direct-to-consumer communications for Roche Pharmaceutical, Schering Plough and Braun. Before transitioning to healthcare communications, Yates spent more than a decade at the advertising agencies J. Walter Thompson, DMB&B and Grey, where he worked on such leading consumer brands as Barilla, M&M Mars, P&G, Kraft, Miller and Northern Telecom.